THE OPTIMIZATION OF TREATMENT OF ESSENCIAL ARTERIAL HYPERTENSION IN EAST KAZAKHSTAN
Introduction.Despite the successes achieved in the treatment of essential hypertension (AH), the problem of treatment of resistant hypertension remains urgent.
In this regard, in many countries around the world, innovative non-drug method of sympathetic denervation of renal arteries using high frequency currents has been widely spread.
Aim. To determine efficacy of sympathetic denervation of renal arteries for the course of resistant hypertension according to the materials of the cardiological department of the University Hospital.
Materials and methods. 86 patients with resistant hypertension were examined and treated during 2014-2017 with the use of a method of catheter sympathetic denervation of renal arteries together with permanent antihypertensive therapy. AH monitoring was performed during the entire period of inpatient treatment, and also during the subsequent 3-6 months after the procedure. Statistic analysis of getting information was carried with SPSS program 12.0.2 for Windows.
Results: It was found that in most cases the application of the above method allows to achieve the target blood pressure level in the next few months after the procedure, accompanied by the need to reduce the daily doses of constantly used medications.
Conclusions: The use of catheter sympathetic denervation of renal vessels in resistant hypertension is a highly effective method of its treatment, which allows improving the quality of life of patients.
Gulzhahan K. Kapanova 1, https://orcid.org/0000-0001-6574-6581
Asya I. Khaibullina 1, https://orcid.org/0000-0002-4017-3083
Аinur S. Botabayeva 1, Мaigul B. Selgazina 1,
Tungyshkhan Ye. Shakhanov 1, Daulet K. Muzdubayev2
1 Department of faculty therapy, 2Student of 4 course, faculty general medicine,
Semey State Medical University, Semey, Republic of Kazakhstan
1. Burnier M. Antihypertensive Combination Treatment: State ofthe Art // Curr Hypertens Rep. 2015; 17:51.11
2. Bhatt D.L., Kandzari D.E., Agostino R. et al. Symplicyty HTN-3 Investigators.A controlled trial of renal denervation for resistant hupertension. N Engl. j. Med. 2014; 370 (15); 1393-401, doi:10,1056/NEJMoa1402670.
3. Byyny R. Hypertension in the Elderly. In. Hypertension: Pathophysiology, Diagnosis and Management, edited by J. Laragh and B. Brenner. Raven Press, New York, 1990, p. 1869-1888.
4. Claxton A.J. et. all. A systematic review of the association between adherence to drug therapy and medication compliance. ClinTher 2012; 23: 1296-1310.
5. Dustan H.P. Essencialhyptrtension: Neural considerations // Medical clinics of North America. 1987. Vol. 71. P. 897-905.
6. Esler M.D., Krum H., Schlaich M., Schmieder R.E., Bohm M. et al. Symplicyty HTN-2 Investigators. Renal symphathetic denervation for treatment of drug- resistant hupertension: one-year results from the Symplicyty HTN-2 randomized, controlled trial // Circulftion. 2012; 126(25); 2976-2982.
7. ESH/ESC Task Forse for the management of arterial hypertension, 2013. Practice Guidelines for the management of the arterial hypertension of the European Society of hypertension and Cardiology // J. Hypertens. 2013; 311925-311938.
8. Guyton A.C. Quantitative Analysis of the pathophysiology of hypertension // J. Amer.Soc. Nephrol. 1999. Vol. 10. P. 2248- 2258.
9. Krum H., Shlaich M. The human sympathetic nervous system: HS relevance in hypertension and heart failure // Eur Heart J. 2012;33:1058-1066.
10. Parati G, Esler M. et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicenter safety and proof-of-principle cohort study // Lancet. 2009; 9671:1275-1281.
11. Mancia G., Fagaed R., et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the ESH and of the ESC // J. Hypertens. 2013; 13:1281-357.
12. Mu L., Mukamal K.J. Treatment Intensification for Hypertension in US Ambulatory Medical Care // J. Am Heart Assoc 2016; 5(10).
13. Myers M.G., Godwin M., Dawes M., Kiss A. et al. Measurement of blood pressure in the office: recognizing the problem and proposing the solution // Hypertension 2010; 55: 195-200.
14. Reckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older // N Engl J. Med 2008: 358: 1887-1898.
15. SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-pressure Control. N Engl J. Med. 2015;373:2103-2116;
16. Schlaich M.P., Sobotka P.A., Krum H., Lambert E. Renal symphathetic - nerve ablation for un controlled hupertension // N. Engl. J. Med 2009; 361(9): 932-34.
17. Takahashi H., Yamasaki H., Takeda K., Okajima H. et al. Retardation of the development of hypertension in DOCA- salt rats by renal denervation // Jpn Circ. J., 1984; 48(6) ; 567-574.
18. Taborsky M. The effect of renal denervation in patients with advanced heart failure: The OMOUC 1 study. Presented at: European Society of Cardiology Congress; August, 27, 2012; Germany.
19. Volobuev A.N., Koshev V.I., Petrov E.S. Biophysikal principles of hemodinamics. New York: Nova Science Publishers, Inc.; 2010, 215 p.
20. Witkovski A.I., Florczak E., Slivinski P. et al. Effekts of renal symphathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea // Hypertension, 2011; 58(4): 559-65
Bibliography link
Капанова Г.К., Хайбуллина А.И., Ботабаева А.С., Селгазина М.Б., Шаханов Т.Е., Муздубаев Д.К. Оптимизация методов лечения эссенциальной артериальной гипертензии в Восточном Казахстане // Наука и Здравоохранение. 2018. 6 (Т.20). С. 138-142.
Kapanova G.K., Khaibullina A.I., Botabayeva А.S., Selgazina М.B., Shakhanov T.Ye., Muzdubayev D.K. The optimization of treatment of essencial arterial hypertension in East Kazakhstan. Nauka i Zdravookhranenie [Science & Healthcare]. 2018, (Vol.20) 6, pp. 138-142.
Капанова Г.К., Хайбуллина А.И., Ботабаева А.С., Селгазина М.Б., Шаханов Т.Е., Муздубаев Д.К. Шығыс Қазақстанда кездесетін эссенциальді артериальді гипертензиясының оптимальді емі // Ғылым және Денсаулық сақтау. 2018. 6 (Т.20). Б. 138-142.